1H-MRS experiences after bilateral DBS of the STN in Parkinson's disease

Parkinsonism and Related Disorders

Volumn 14, Issue 3, 2008, Pages 229-232

  Llumiguano, C ^a   Kovacs, N ^a   Usprung, Zs ^b   Schwarcz, A ^a   Doczi T P ^a   Balas, I ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Diagnostic Center of Pecs   (Hungary)

Author keywords

DBS; MR spectroscopy; Parkinson's disease; STN

Indexed keywords

CHOLINE; CREATINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; DIAGNOSTIC AGENT; PROTON;

ADULT; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; FEMALE; FRONTAL CORTEX; GLOBUS PALLIDUS; HUMAN; LEFT HEMISPHERE; MALE; MEDICAL INSTRUMENTATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RIGHT HEMISPHERE; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME; UNIFIED PARKINSON DISEASE RATING SCALE; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

AGED; ASPARTIC ACID; CHOLINE; CREATINE; DEEP BRAIN STIMULATION; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PARKINSON DISEASE; PROTONS; SUBTHALAMIC NUCLEUS;

EID: 41549168723     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2007.08.009     Document Type: Article

References (25)

1. Valldeoriola F., Pilleri M., Tolosa E., Molinuevo J.L., Rumia J., and Ferrer E. Bilateral subthalamic stimulation monotherapy in advanced Parkinson's disease: long-term follow-up of patients. Mov Disord 17 1 (2002) 125-132
2. Ostergaard K., Sunde N., and Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 17 4 (2002) 693-700
3. Kleiner-Fisman G., Fisman D.N., Sime E., Saint-Cyr J.A., Lozano A.M., and Lang A.E. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J Neurosurg 99 3 (2003) 489-495
4. Rodriguez-Oroz M.C., Zamarbide I., Guridi J., Palmero M.R., and Obeso J.A. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation. J Neurol Neurosurg Psychiatry 75 10 (2004) 1382-1385
5. Drapier S., Raoul S., Drapier D., Leray E., Lallement F., Rivier I., et al. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease. J Neurol 252 5 (2005) 583-588
6. Lyons K.E., and Pahwa R. Long-term benefits in quality of life provided by bilateral subthalamic stimulation in patients with Parkinson disease. J Neurosurg 103 2 (2005) 252-255
7. Kleiner-Fisman G., Herzog J., Fisman D.N., Tamma F., Lyons K.E., Pahwa R., et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 21 Suppl 14 (2006) S290-S304
8. Urenjak J., Williams S.R., Gadian D.G., and Noble M. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types. J Neurosci 13 3 (1993) 981-989
9. Vion-Dury J., Meyerhoff D.J., Cozzone P.J., and Weiner M.W. What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?. J Neurol 241 6 (1994) 354-371
10. Clarke C.E., Lowry M., and Horsman A. Unchanged basal ganglia N-acetylaspartate and glutamate in idiopathic Parkinson's disease measured by proton magnetic resonance spectroscopy. Mov Disord 12 3 (1997) 297-301
11. Holshouser B.A., Komu M., Möller H.E., Zijlmans J., Kolem H., Hinshaw Jr. D.B., et al. Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magn Reson Med 33 5 (1995) 589-594
12. Ellis C.M., Lemmens G., Williams S.C., Simmons A., Dawson J., Leigh P.N., et al. Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology 49 2 (1997) 438-444
13. Tedeschi G., Litvan I., Bonavita S., Bertolina A., Lundbom N., Patronas N.J., et al. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain 120 Pt 9 (1997) 1541-1552
14. Federico F., Simone I.L., Lucivero V., Iliceto G., De Mari M., Giannini P., et al. Proton magnetic resonance spectroscopy and atypical parkinsonian disorders. Mov Disord 12 6 (1997) 903-909
15. Hoang T.Q., Bluml S., Dubowitz D.J., Moats R., Kopyov O., Jacques D., et al. Quantitative proton-decoupled 31P MRS and 1 H MRS in the evaluation of Huntington's and Parkinson's diseases. Neurology 50 4 (1998) 1033-1040
16. Hu M.T., Taylor-Robinson S.D., Chaudhuri K.R., Bell J.D., Morris R.G., Clough C., et al. Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry 67 1 (1999) 20-26
17. Danielsen E.R., and Ross B.D. The clinical significance of metabolites. In: Danielsen E.R., and Ross B. (Eds). Magnetic resonance spectroscopy diagnosis of neurological diseases (1999), Dekker, New York 23-43
18. Lucetti C., Del Dotto P., Gambaccini G., Bernardini S., Bianchi M.C., Tosetti M., et al. Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. Neurol Sci 22 1 (2001) 69-70
19. O'Neill J., Schuff N., Marks Jr. W.J., Feiwell R., Aminoff M.J., and Weiner M.W. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 17 5 (2002) 917-927
20. Axelson D., Bakken I.J., Gribbestad I., Ehrnholm B., Nilsen G., and Aasly J. Applications of neural network analyses to in vivo 1 H magnetic resonance spectroscopy of Parkinson disease patients. J Magn Reson Imaging 16 1 (2002) 13-20
21. Baik H.M., Choe B.Y., Son B.C., Jeun S.S., Kim M.C., Lee K.S., et al. Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy. Eur J of Radiol 47 3 (2003) 179-187
22. Camicioli R.M., Korzan J.R., Foster S.L., Fisher N.J., Emery D.J., Bastos A.C., et al. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett 354 3 (2004) 177-180
23. Balas I., Llumiguano C., Horvath Z., Kover F., and Doczi T. Stereotactic thalamotomy for parkinsonian and others types of tremor. Experiences of thalamic multiunit burst activity by means of semi-microelectrode. Rev Neurol 32 6 (2001) 520-524
24. Balás I., Llumiguano C., and Dóczi T.P. Ablative stereotactic surgery improves manual performance time in Parkinson's disease. Parkinsonism Related Disord 12 4 (2006) 223-227
25. LLumiguano C., Dóczi T.P., and Balás I. Microelectrode guided stereotactic pallidotomy and pallido-thalamotomy for the treatment of Parkinson's disease. Neurocirugia (Astur) 17 5 (2006) 420-432